A 0.5% adenine diet significantly increased aortic valve calibrated integrated backscatter values at 9 weeks (16.4 vs 13.3 dB, p=0.001), which normalized after 12 weeks of diet cessation.
Can echocardiographic calibrated integrated backscatter (cIB) accurately monitor the progression and regression of aortic valvular calcifications in a rat model of CAVD?
Echocardiographic calibrated integrated backscatter is a valid non-invasive tool for quantitatively monitoring the progression and regression of calcific aortic valve disease in a rat model.
Absolute Event Rate: 16.4% vs 13.3%
p-value: p=0.001
BACKGROUND: Calcification is an independent predictor of mortality in calcific aortic valve disease (CAVD). The aim of this study was to evaluate the use of non-invasive, non-ionizing echocardiographic calibrated integrated backscatter (cIB) for monitoring progression and subsequent regression of aortic valvular calcifications in a rat model of reversible renal failure with CAVD, compared to histology. METHODS: 28 male Wistar rats were prospectively followed during 21 weeks. Group 1 (N=14) was fed with a 0.5% adenine diet for 9 weeks to induce renal failure and CAVD. Group 2 (N=14) received a standard diet. At week 9, six animals of each group were killed. The remaining animals of group 1 (N=8) and group 2 (N=8) were kept on a standard diet for an additional 12 weeks. cIB of the aortic valve was calculated at baseline, 9 and 21 weeks, followed by measurement of the calcified area (Ca Area) on histology. RESULTS: At week 9, cIB values and Ca Area of the aortic valve were significantly increased in the adenine-fed rats compared to baseline and controls. After 12 weeks of adenine diet cessation, cIB values and Ca Area of group 1 decreased compared to week 9, while there was no longer a significant difference compared to age-matched controls of group 2. CONCLUSIONS: cIB is a non-invasive tool allowing quantitative monitoring of CAVD progression and regression in a rat model of reversible renal failure, as validated by comparison with histology. This technique might become useful for assessing CAVD during targeted therapy.
Roosens et al. (Tue,) conducted a other in Calcific aortic valve disease (CAVD) and renal failure (n=28). 0.5% adenine diet vs. Standard diet was evaluated on Calibrated integrated backscatter (cIB) of the total aortic valve (ROI AVTOT) at week 9 (p=0.001). A 0.5% adenine diet significantly increased aortic valve calibrated integrated backscatter values at 9 weeks (16.4 vs 13.3 dB, p=0.001), which normalized after 12 weeks of diet cessation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: